Prenetics Global Limited (PRENW) Stock Analysis

What Prenetics Global Limited does

Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.

Key metrics

ETFs linked to PRENW

Broad-market and Healthcare sector ETFs an investor holding Prenetics Global Limited is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PRENW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Prenetics Global Limited?

Prenetics Global Limited trades under the ticker PRENW on NASDAQ.

Which exchange is PRENW listed on?

PRENW is listed on NASDAQ.

What sector does Prenetics Global Limited operate in?

Prenetics Global Limited is classified in the Healthcare sector (Medical - Diagnostics & Research industry).

How can PortView help analyze PRENW in a portfolio?

PortView shows PRENW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.